TissGeneSummary for PHF7 |
Gene summary |
Basic gene information | Gene symbol | PHF7 |
Gene name | PHD finger protein 7 | |
Synonyms | HSPC045|HSPC226|NYD-SP6 | |
Cytomap | UCSC genome browser: 3p21.1 | |
Type of gene | protein-coding | |
RefGenes | NM_001278221.1, NM_016483.5,NM_173341.1, | |
Description | testis development protein NYD-SP6 | |
Modification date | 20141207 | |
dbXrefs | HGNC : HGNC | |
Ensembl : ENSG00000010318 | ||
HPRD : 15127 | ||
Vega : OTTHUMG00000158495 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_PHF7 | |
BioGPS: 51533 | ||
Pathway | NCI Pathway Interaction Database: PHF7 | |
KEGG: PHF7 | ||
REACTOME: PHF7 | ||
Pathway Commons: PHF7 | ||
Context | iHOP: PHF7 | |
ligand binding site mutation search in PubMed: PHF7 | ||
UCL Cancer Institute: PHF7 | ||
Assigned class in TissGDB* | B | |
Included tissue-specific gene expression resources | HPA,TiGER,GTEx | |
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | Testis | |
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | TGCT | |
Reference showing the relevant tissue of PHF7 | ||
Description by TissGene annotations |
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO term | PubMed ID |
Top |
TissGeneExp for PHF7 |
Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
KICH | 0.984590943 | -0.048361057 | 1.032952 | 1.00E-06 | 3.75E-06 |
COAD | -0.972370441 | 0.330894943 | -1.303265385 | 3.95E-08 | 3.03E-07 |
Top |
TissGene-miRNA for PHF7 |
Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
ACC | hsa-miR-378f | MIMAT0018932 | 0.017 | -0.27 | 78 |
ACC | hsa-miR-378f | MIMAT0018932 | 0.017 | -0.27 | 78 |
LUAD | hsa-miR-495-3p | MIMAT0002817 | 0.028 | -0.29 | 60 |
Top |
TissGeneMut for PHF7 |
TissGeneSNV for PHF7 |
nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
- nsSNVs sorted by frequency. |
AAchange | Cancer type | # samples |
p.P317S | SKCM | 2 |
p.E165K | HNSC | 1 |
p.R210Q | BLCA | 1 |
p.Q151* | SKCM | 1 |
p.K7N | HNSC | 1 |
p.H200Y | PRAD | 1 |
p.F60V | PAAD | 1 |
p.D260Y | UCEC | 1 |
p.R145C | SKCM | 1 |
p.T344S | ACC | 1 |
p.V57M | COAD | 1 |
p.H144Y | UCS | 1 |
p.P69H | STAD | 1 |
p.K87N | COAD | 1 |
p.E44* | LUAD | 1 |
p.P347S | ESCA | 1 |
p.P214S | SKCM | 1 |
p.A303V | SKCM | 1 |
p.P69H | UCEC | 1 |
p.N54D | LIHC | 1 |
p.Y245C | KIRP | 1 |
p.R92Q | UCEC | 1 |
p.E212* | UCEC | 1 |
p.G280E | SKCM | 1 |
p.S313A | COAD | 1 |
p.W343* | ESCA | 1 |
p.E337K | BLCA | 1 |
p.T196A | UCEC | 1 |
p.R289K | SKCM | 1 |
p.A194V | LUAD | 1 |
p.L335M | COAD | 1 |
p.R71S | COAD | 1 |
p.K104R | SARC | 1 |
p.R244H | ESCA | 1 |
Top |
TissGeneCNV for PHF7 |
Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
Top |
TissGeneFusions for PHF7 |
Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
Chimerdb3.0 | ChiTaRs | NA | AL137671 | PHF7-PHF7 | chr3:52457299 | chr3:52456731 |
Top |
TissGeneNet for PHF7 |
Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
Top |
TissGeneProg for PHF7 |
Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Top |
TissGeneClin for PHF7 |
TissGeneDrug for PHF7 |
Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
TissGeneDisease for PHF7 |
Disease information associated with TissGene (DisGeNet, 2016-06-01) |
Disease ID | Disease name | # pubmeds | Source |